SHL Medical will be exhibiting at CPHI Japan 2026, taking place from April 21 to 23 at Tokyo Big Sight, Tokyo, Japan. CPHI Japan is a key regional event that brings together pharmaceutical and biotech companies across the Asia-Pacific region to exchange insights on drug development, manufacturing, and supply.
At this year’s exhibition, we will highlight our latest device solutions, Quanta and Reunite, which will be presented in Japan for the first time following their launch. These devices will be showcased alongside established platforms, including Molly and Maggie, offering a broad view of SHL Medical’s self-injection device portfolio and the ongoing evolution of our technologies.
With more than 1.5 billion autoinjectors shipped worldwide and over 35 years of industry experience, SHL Medical supports pharma and biotech partners through integrated, in-house capabilities. Our established operational footprint in Asia brings these capabilities closer to regional development and manufacturing needs, addressing diverse formulation properties, use scenarios, and long-term supply demands.
We look forward to connecting with you at Booth #2G-42 at CPHI Japan 2026.
